The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
STU:AS00's 9-Day RSI is ranked better than 73.91% of 1418
companies
in the Biotechnology industry
Industry Median: 51.815
vs STU:AS00: 41.66
European Medical Solutions (STU:AS00) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
European Medical Solutions 9-Day RSI Related Terms
STU:AS00 vs VRTX, REGN, ALNY: 9-Day RSI Comparison
For the Biotechnology subindustry, European Medical Solutions's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
European Medical Solutions 9-Day RSI vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, European Medical Solutions's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where European Medical Solutions's 9-Day RSI falls into.
European Medical Solutions (STU:AS00) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
European Medical Solutions (STU:AS00) has a 9-Day RSI of 41.66 as of Jul. 09, 2026. According to the industry distribution chart, European Medical Solutions ranks #370 out of 1418 companies in the Biotechnology industry, placing it in the top 26.1%.
Is European Medical Solutions' 9-Day RSI too high?
European Medical Solutions' current 9-Day RSI is 41.66. The Biotechnology industry median 9-Day RSI is 51.82. European Medical Solutions' value of 41.66 is 19.6% below this industry median. Based on the distribution chart, European Medical Solutions ranks #370 out of 1418 companies in the Biotechnology industry, which is above the industry midpoint. Overall, European Medical Solutions has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' 9-Day RSI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, European Medical Solutions ranks #370 out of 1418 companies for 9-Day RSI. This puts European Medical Solutions in the upper half of its industry. The industry median 9-Day RSI is 51.82. European Medical Solutions' value of 41.66 is 19.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Biotechnology company?
The median 9-Day RSI among Biotechnology companies is 51.82, based on 1,418 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. European Medical Solutions's current 9-Day RSI of 41.66 is 19.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median 9-Day RSI is 51.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. European Medical Solutions's current 9-Day RSI is 41.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
European Medical Solutions (STU:AS00) has a current 9-Day RSI of 41.66. The stock's GF Value™ is €8.16, compared to a current price of €4.70 — trading 42.4% below its estimated fair value. The current 9-Day RSI is 41.66 and 19.6% below the Biotechnology industry median of 51.82. European Medical Solutions' overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current 9-Day RSI is 41.66 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is European Medical Solutions (STU:AS00) Overvalued in 2026?
Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued.
The current stock price of €4.70 is trading 42.4% below its estimated GF Value™ of €8.16.
Key valuation signals for STU:AS00:
9-Day RSI: 41.66
GF Value™: €8.16 vs. price of €4.70 (42.4% below fair value)
Industry Position: 19.6% below the Biotechnology median (#370 of 1418)
No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
48GF Score
Get the complete analysis for STU:AS00
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:AS00 has been successfully added to your 